Autolus Therapeutics

/Autolus Therapeutics

We are a biopharmaceutical company developing next-generation programmed T cell therapies for the treatment of cancer

Symbol

Price Range
$15.00 - $17.00

Final Shares
7,800,000

Anticipated Date
TBD

Underwriters

To view the prospectus for IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange